Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1568799

registered interest
date	19/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the terms of reference for the national dementia mission.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	127723
answer	answer is ministerial correction date of answer 27/01/2023 answer text <p>We are in the process of developing plans for this mission. We cannot yet confirm when we will publish the terms of reference for the mission.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 27/01/2023 14:30:17 answering member 4527 label Biography information for Helen Whately
tabling member	1585 label Biography information for Stephen Hammond

1568800

registered interest
date	19/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking enable charities and patient organisations to feed into the dementia mission led by Dame Barbara Windsor.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	127724
answer	answer is ministerial correction date of answer 27/01/2023 answer text <p>We are in the process of developing plans for this mission, engaging with a wide variety of stakeholders, including leading charities and patient organisations in the dementia and neurodegeneration space. We will continue to involve them as our plans develop.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 27/01/2023 14:31:50 answering member 4527 label Biography information for Helen Whately
tabling member	1585 label Biography information for Stephen Hammond

1549607

registered interest
date	07/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve survival rates from sudden cardiac arrest.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	105331
answer	answer is ministerial correction date of answer 16/12/2022 answer text <p>NHS England announced in the NHS Long Term Plan it will work with partners to improve community first response and build defibrillator networks to improve survival from out-of-hospital cardiac arrest.</p><p> </p><p>A national network of community first responders and defibrillators will save up to 4,000 lives each year by 2028.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 16/12/2022 14:21:20 answering member 4527 label Biography information for Helen Whately
tabling member	1585 label Biography information for Stephen Hammond

1537875

registered interest
date	01/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on delivering additional medical scans, tests and check-ups.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	901965
answer	answer is ministerial correction date of answer 01/11/2022 answer text <p>As part of our work to bust the Covid backlogs we have so far rolled out 89 Community Diagnostic Centres that have delivered over 2 million additional tests since June 2021, and will deliver capacity for up to 9 million additional tests a year from 2025.</p> answering member constituency Colchester answering member printed Will Quince question first answered 01/11/2022 17:19:56 answering member 4423 label Biography information for Will Quince
tabling member	1585 label Biography information for Stephen Hammond

1470831

registered interest
date	15/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus and Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of narrowing the eligibility criteria for influenza vaccination and the JCVI's advice to reduce the age cohort for the autumn covid-19 booster programme; and whether that change would place increased pressure on NHS capacity during the winter season.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	18855
answer	answer is ministerial correction date of answer 27/07/2022 answer text <p>On 15 July 2022, the Government provided an update on the COVID-19 autumn booster programme and flu vaccination programme. This included the expansion of the eligibility criteria for flu vaccinations to be offered to all adults aged 50 years old and over and secondary school children in Years 7, 8, and 9 in England. These additional groups will be eligible once the most vulnerable, including previously announced pre-school and primary school children, those aged 65 years old and over and those in clinical risk groups have been offered the vaccination. This expansion aims to reduce the level of serious illness and subsequent pressure on the National Health Service.</p><p>the Government accepted the JCVI’s advice to offer an autumn booster vaccination to increase immunity in those at higher risk from COVID-19 and protect against severe illness, hospitalisation and death in winter 2022/23. The booster dose will be offered to residents and staff in a care home for older adults; all adults aged 50 years old and over; those aged five to 49 years old in a clinical risk group or who are household contacts of someone with immunosuppression; frontline health and social care workers; and carers aged 16 years old and over. This aims to increase immunity in those at higher risk from COVID-19 and protect against severe illness, hospitalisation and death in winter 2022/23.</p><p><strong> </strong></p> answering member constituency Erewash answering member printed Maggie Throup question first answered 27/07/2022 08:31:25 answering member 4447 label Biography information for Maggie Throup
tabling member	1585 label Biography information for Stephen Hammond

1470832

registered interest
date	15/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Medical Treatments and Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to transition covid-19 treatments into routine healthcare provision, including placing covid-19 vaccinations into the National Immunisation Programme and the provision of antiviral treatments for recommended groups.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	18856
answer	answer is ministerial correction date of answer 30/06/2022 answer text <p>The Department is working with the National Health Service and other partners to transition COVID-19 treatments such as antivirals, therapeutics, and vaccinations into routine healthcare provision. We aim to learn from the pandemic response to design a model which minimises the impact on other health and care services in times of greatest demand.</p><p>We await the results of the PANORAMIC study to determine how those who would benefit most from COVID-19 antivirals can continue to access treatments through the NHS, including the delivery of vaccinations.</p><p><strong> </strong></p> answering member constituency Erewash answering member printed Maggie Throup question first answered 30/06/2022 10:49:57 answering member 4447 label Biography information for Maggie Throup
tabling member	1585 label Biography information for Stephen Hammond

1470833

registered interest
date	15/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the role of covid-19 antivirals in reducing pressures on the NHS.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	18857
answer	answer is ministerial correction date of answer 23/06/2022 answer text <p>No specific assessment has been made. However, clinical trial results indicate that the dual oral antiviral nirmatrelvir/ritonavir resulted in a relative risk reduction of hospitalisation or death by 88% within five days of symptom onset, compared to placebo in non-hospitalised, high-risk adults with COVID-19. Further results show that the oral antiviral molnupiravir administered within five days of symptom onset to high-risk, non-hospitalised patients resulted in a relative risk reduction of 30% in the composite primary outcome of hospitalisation or death at day 29.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 23/06/2022 14:03:40 answering member 4447 label Biography information for Maggie Throup
tabling member	1585 label Biography information for Stephen Hammond

1470834

registered interest
date	15/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department's plans to expand the eligibility for antivirals to include patients that remain at moderate to high risk of developing severe covid-19.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	18858
answer	answer is ministerial correction date of answer 24/06/2022 answer text <p>The PANORAMIC national study is gathering further evidence on which patients would benefits most from oral antiviral treatments for COVID-19. The results from this study inform clinical policy on access to these treatments through the National Health Service, including any expansion of the eligible patient cohorts.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 24/06/2022 11:46:30 answering member 4447 label Biography information for Maggie Throup
tabling member	1585 label Biography information for Stephen Hammond

1470835

registered interest
date	15/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the rollout of covid-19 antivirals; and what comparative assessment his Department has made of his Department's rollout of covid-19 antivirals with other comparator countries.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	18859
answer	answer is ministerial correction date of answer 24/06/2022 answer text <p>We are continuing to monitor the deployment of COVID-19 antivirals. In the week commencing 6 June 2022, approximately 1,600 non-hospitalised patients in the United Kingdom have received these treatments, with the total number of patients treated at approximately 63,000.</p><p> </p><p>The UK Health Security Agency is also monitoring the effectiveness of the COVID-19 therapeutics nirmatrelvir+ritonavir (Paxlovid), molnupiravir and remdesivir. Both molnupiravir and Paxlovid are being trialled as part of the PANORAMIC national study. Results from the molnupiravir section of the PANORAMIC national study are expected later this summer. The Antivirals and Therapeutics Taskforce is engaging with other nations on the use, deployment and evaluation of COVID-19 therapeutics and antivirals, which will inform our approach.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 24/06/2022 11:50:29 answering member 4447 label Biography information for Maggie Throup
tabling member	1585 label Biography information for Stephen Hammond

1415922

registered interest
date	24/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Covid Pass: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to facilitate the rollout of the international NHS COVID pass to 12-15 year olds before half term in February 2022.
tabling member constituency	Wimbledon
tabling member printed	Stephen Hammond
uin	110307
answer	answer is ministerial correction date of answer 31/01/2022 answer text <p>Since 13 December 2021, fully vaccinated 12 to 15 year olds can demonstrate their vaccination status using an NHS COVID Pass travel letter. From 3 February 2022, children aged 12 years old and over can access a digital NHS COVID Pass for international travel. The digital NHS COVID Pass will provide a record of vaccinations received and evidence of prior infection or recovery for 180 days following a positive National Health Service polymerase chain reaction test. The pass will be available via NHS.UK for those aged 12 years old and over and via the NHS App for those aged 13 years old and over.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 31/01/2022 10:05:39 answering member 4447 label Biography information for Maggie Throup
tabling member	1585 label Biography information for Stephen Hammond